Metabolic surgery-principles and current concepts

Langenbeck's Archives of Surgery

Volumn 396, Issue 7, 2011, Pages 949-972

  Gass, M ^a   Beglinger, C ^b   Peterli, R ^a  

^a St Claraspital Basel ^*  (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Bariatric surgery; Diabetes; Gut hormones; Metabolic surgery; Obesity

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; BILE ACID; CHOLECYSTOKININ; DIPEPTIDYL PEPTIDASE IV; GASTRIC INHIBITORY POLYPEPTIDE; GHRELIN; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 2; GLUCOSE TRANSPORTER 4; LEPTIN; PEPTIDE YY [3-36];

BARIATRIC SURGERY; BILIOPANCREATIC BYPASS; COLON; DISEASE SEVERITY; GASTRIC BANDING; GASTROENTEROSTOMY; GASTROJEJUNOSTOMY; GASTROPLASTY; GLUCOSE HOMEOSTASIS; GLYCEMIC INDEX; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; JEJUNOILEAL BYPASS; LAPAROSCOPIC SURGERY; MALABSORPTION; METABOLIC SURGERY; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; REVIEW; ROUX Y ANASTOMOSIS; SLEEVE GASTRECTOMY; SMALL INTESTINE; STOMACH BYPASS; SURGICAL APPROACH; SURGICAL TECHNIQUE; WEIGHT REDUCTION;

BARIATRIC SURGERY; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL HORMONES; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; OBESITY, MORBID; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 80052858817     PISSN: 14352443     EISSN: 14352451     Source Type: Journal    
DOI: 10.1007/s00423-011-0834-3     Document Type: Review

References (271)

1. PG Kopelman 2000 Obesity as a medical problem Nature 404 6778 635 643 10.1038/35007508 10766250 1:CAS:528:DC%2BD3cXis1Grtb8%3D (Pubitemid 30205068)
2. R Sturm 2007 Increases in morbid obesity in the USA: 2000-2005 Public Health 121 7 492 496 j.jhep.2010.12.004/j.puhe.2007.01.006 17399752 1:STN:280:DC%2BD2szlsFGjsw%3D%3D (Pubitemid 46895458)
3. E Karra K Chandarana RL Batterham 2009 The role of peptide YY in appetite regulation and obesity J Physiol 587 Pt 1 19 25 10.1113/jphysiol.2008.164269 19064614 1:CAS:528:DC%2BD1MXhtVKlsrc%3D
4. KM Flegal BI Graubard DF Williamson MH Gail 2005 Excess deaths associated with underweight, overweight, and obesity Jama 293 15 1861 1867 10.1001/jama.293.15.1861 15840860 1:CAS:528:DC%2BD2MXjtl2hurk%3D (Pubitemid 40548182)
5. KM Flegal BI Graubard DF Williamson MH Gail 2007 Cause-specific excess deaths associated with underweight, overweight, and obesity Jama 298 17 2028 2037 10.1001/jama.298.17.2028 17986696 1:CAS:528:DC%2BD2sXht1yjsLjF (Pubitemid 350074800)
6. Schneider H, Schmid A (2004) Die Kosten der Adipositas in der Schweiz. Schlussbericht des Bundesamt für Gesundheit (BAG)Bern, Schweiz.
7. L Sjostrom AK Lindroos M Peltonen J Torgerson C Bouchard B Carlsson S Dahlgren B Larsson K Narbro CD Sjostrom M Sullivan H Wedel 2004 Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery N Engl J Med 351 26 2683 2693 10.1056/NEJMoa035622 15616203 (Pubitemid 39665322)
8. L Sjostrom K Narbro CD Sjostrom K Karason B Larsson H Wedel T Lystig M Sullivan C Bouchard B Carlsson C Bengtsson S Dahlgren A Gummesson P Jacobson J Karlsson AK Lindroos H Lonroth I Naslund T Olbers K Stenlof J Torgerson G Agren LM Carlsson 2007 Effects of bariatric surgery on mortality in Swedish obese subjects N Engl J Med 357 8 741 752 10.1056/NEJMoa066254 17715408 (Pubitemid 47295641)
9. TD Adams RE Gress SC Smith RC Halverson SC Simper WD Rosamond MJ Lamonte AM Stroup SC Hunt 2007 Long-term mortality after gastric bypass surgery N Engl J Med 357 8 753 761 10.1056/NEJMoa066603 17715409 1:CAS:528:DC%2BD2sXpsF2iu7k%3D (Pubitemid 47295642)
10. H Buchwald JN Buchwald 2002 Evolution of operative procedures for the management of morbid obesity 1950-2000 Obes Surg 12 5 705 717 10.1381/096089202321019747 12448398 (Pubitemid 35305755)
11. MP Hocking MC Duerson JP O'Leary ER Woodward 1983 Jejunoileal bypass for morbid obesity. Late follow-up in 100 cases N Engl J Med 308 17 995 999 10.1056/NEJM198304283081703 6835318 1:STN:280:DyaL3s7mslemsQ%3D%3D (Pubitemid 13118704)
12. JD Halverson L Wise MF Wazna WF Ballinger 1978 Jejunoileal bypass for morbid obesity. A critical appraisal Am J Med 64 3 461 475 345803 1:STN:280:DyaE1c7kt1Wnuw%3D%3D (Pubitemid 8302305)
13. MZ Schwartz RL Varco H Buchwald 1973 Preoperative preparation, operative technique, and postoperative care of patients undergoing jejunoileal bypass for massive exogenous obesity J Surg Res 14 2 147 150 4693918 1:STN:280: DyaE3s7ks1KqsQ%3D%3D
14. KG MacDonald Jr SD Long MS Swanson BM Brown P Morris GL Dohm WJ Pories 1997 The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus J Gastrointest Surg 1 3 213 220 9834350 discussion 220 (Pubitemid 127432762)
15. EJ Demaria DA Winegar VW Pate NE Hutcher J Ponce WJ Pories 2010 Early postoperative outcomes of metabolic surgery to treat diabetes from sites participating in the ASMBS bariatric surgery center of excellence program as reported in the Bariatric Outcomes Longitudinal Database Ann Surg 252 3 559 566 10.1097/SLA.0b013e3181f2aed0 20739857 discussion 566-557
16. H Buchwald R Estok K Fahrbach D Banel MD Jensen WJ Pories JP Bantle I Sledge 2009 Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis Am J Med 122 3 248 256 j.jhep.2010.12.004/j.amjmed. 2008.09.041 19272486 e245
17. H Buchwald Y Avidor E Braunwald MD Jensen W Pories K Fahrbach K Schoelles 2004 Bariatric surgery: a systematic review and meta-analysis Jama 292 14 1724 1737 10.1001/jama.292.14.1724 15479938 1:CAS:528:DC%2BD2cXos1OjtLg%3D (Pubitemid 39346675)
18. CW le Roux SJ Aylwin RL Batterham CM Borg F Coyle V Prasad S Shurey MA Ghatei AG Patel SR Bloom 2006 Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters Ann Surg 243 1 108 114 16371744 (Pubitemid 43054062)
19. M Bueter C Lowenstein T Olbers M Wang NL Cluny SR Bloom KA Sharkey TA Lutz CW le Roux 2010 Gastric bypass increases energy expenditure in rats Gastroenterology 138 5 1845 1853 10.1053/j.gastro.2009.11.012 19931268
20. KE Steele GP Prokopowicz MA Schweitzer TH Magunsuon AO Lidor H Kuwabawa A Kumar J Brasic DF Wong 2010 Alterations of central dopamine receptors before and after gastric bypass surgery Obes Surg 20 3 369 374 10.1007/s11695-009-0015- 4 19902317
21. DE Cummings J Overduin KE Foster-Schubert MJ Carlson 2007 Role of the bypassed proximal intestine in the anti-diabetic effects of bariatric surgery Surg Obes Relat Dis 3 2 109 115 j.jhep.2010.12.004/j.soard.2007.02.003 17386391 (Pubitemid 46444709)
22. DJ Drucker 2002 Biological actions and therapeutic potential of the glucagon-like peptides Gastroenterology 122 2 531 544 11832466 1:CAS:528:DC%2BD38XhsVGnsLo%3D (Pubitemid 34117003)
23. AJ Kremen JH Linner CH Nelson 1954 An experimental evaluation of the nutritional importance of proximal and distal small intestine Ann Surg 140 3 439 448 13198079 1:CAS:528:DyaG2MXhvVOk
24. JH Payne LT DeWind 1969 Surgical treatment of obesity Am J Surg 118 2 141 147 5798387 1:STN:280:DyaF1M3ltFSgtg%3D%3D
25. H Buchwald RL Varco 1971 A bypass operation for obese hyperlipidemic patients Surgery 70 1 62 70 5092117 1:STN:280:DyaE3M3jsFSgsQ%3D%3D
26. Buchwald H, Rucker RD (1987) The rise and fall of jejunoileal bypass. In: Nelson RL, Nyhus LM (eds) Surgery of the small intestine. Appleton Century Crofts, Norwalk, CT, pp 529-541
27. S Gustavsson A Westling 2002 Laparoscopic adjustable gastric banding: complications and side effects responsible for the poor long-term outcome Semin Laparosc Surg 9 2 115 124 12152154
28. H Buchwald DM Oien 2009 Metabolic/bariatric surgery worldwide 2008 Obes Surg 19 12 1605 1611 10.1007/s11695-009-0014-5 19885707
29. KJ Printen EE Mason 1973 Gastric surgery for relief of morbid obesity Arch Surg 106 4 428 431 4696714 1:STN:280:DyaE3s7lsVygug%3D%3D
30. CA Gomez 1979 Gastroplasty in morbid obesity Surg Clin North Am 59 6 1113 1120 531744 1:STN:280:DyaL3c7isVGgug%3D%3D
31. EE Mason 1982 Vertical banded gastroplasty for obesity Arch Surg 117 5 701 706 7073493 1:STN:280:DyaL387otFKjsQ%3D%3D (Pubitemid 12161833)
32. GV Eckhout OL Willbanks JT Moore 1986 Vertical ring gastroplasty for morbid obesity. Five year experience with 1,463 patients Am J Surg 152 6 713 716 3789301 1:STN:280:DyaL2s%2Fntl2rtg%3D%3D
33. P Forsell D Hallberg G Hellers 1993 Gastric banding for morbid obesity: initial experience with a new adjustable band Obes Surg 3 4 369 374 10.1381/096089293765559052 10757948 (Pubitemid 24014291)
34. LI Kuzmak 1991 A review of seven years' experience with silicone gastric banding Obes Surg 1 4 403 408 10.1381/096089291765560809 10775942
35. R Peterli BK Wolnerhanssen T Peters B Kern C Ackermann M von Flue 2007 Prospective study of a two-stage operative concept in the treatment of morbid obesity: primary lap-band followed if needed by sleeve gastrectomy with duodenal switch Obes Surg 17 3 334 340 17546841 (Pubitemid 46659293)
36. BK Wolnerhanssen T Peters B Kern A Schotzau C Ackermann M von Flue R Peterli 2008 Predictors of outcome in treatment of morbid obesity by laparoscopic adjustable gastric banding: results of a prospective study of 380 patients Surg Obes Relat Dis 4 4 500 506 j.jhep.2010.12.004/j.soard.2008.03.252 18586562
37. Y Van Nieuwenhove W Ceelen A Stockman H Vanommeslaeghe E Snoeck K Van Renterghem D Van de Putte P Pattyn 2011 Long-term results of a prospective study on laparoscopic adjustable gastric banding for morbid obesity Obes Surg 21 5 582 587 10.1007/s11695-010-0341-6 21188545
38. C Boza C Gamboa D Awruch G Perez A Escalona L Ibanez 2010 Laparoscopic Roux-en-Y gastric bypass versus laparoscopic adjustable gastric banding: five years of follow-up Surg Obes Relat Dis 6 5 470 475 10.1016/j.soard.2010.02.045 20702146
39. C Boza C Gamboa G Perez F Crovari A Escalona F Pimentel A Raddatz S Guzman L Ibanez 2011 Laparoscopic adjustable gastric banding (LAGB): surgical results and 5-year follow-up Surg Endosc 25 1 292 297 10.1007/s00464-010-1176-x 20652325
40. AF Dixon JB Dixon PE O'Brien 2005 Laparoscopic adjustable gastric banding induces prolonged satiety: a randomized blind crossover study J Clin Endocrinol Metab 90 2 813 819 10.1210/jc.2004-1546 15585553 1:CAS:528:DC%2BD2MXhsVCgsb4%3D (Pubitemid 40279202)
41. PE O'Brien JB Dixon 2003 Laparoscopic adjustable gastric banding in the treatment of morbid obesity Arch Surg 138 4 376 382 10.1001/archsurg.138.4.376 12686523 (Pubitemid 36417674)
42. PE O'Brien JB Dixon C Laurie S Skinner J Proietto J McNeil B Strauss S Marks L Schachter L Chapman M Anderson 2006 Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial Ann Intern Med 144 9 625 633 16670131 (Pubitemid 46780646)
43. PE O'Brien SM Sawyer C Laurie WA Brown S Skinner F Veit E Paul PR Burton M McGrice M Anderson JB Dixon 2010 Laparoscopic adjustable gastric banding in severely obese adolescents: a randomized trial Jama 303 6 519 526 10.1001/jama.2010.81 20145228
44. JB Dixon PE O'Brien J Playfair L Chapman LM Schachter S Skinner J Proietto M Bailey M Anderson 2008 Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial Jama 299 3 316 323 10.1001/jama.299.3.316 18212316 1:CAS:528:DC%2BD1cXhtFertLs%3D (Pubitemid 351159368)
45. EE Mason C Ito 1967 Gastric bypass in obesity Surg Clin North Am 47 6 1345 1351 6073761 1:STN:280:DyaF1c%2Fpt1Ohsg%3D%3D
46. WO Griffen Jr VL Young CC Stevenson 1977 A prospective comparison of gastric and jejunoileal bypass procedures for morbid obesity Ann Surg 186 4 500 509 907395 (Pubitemid 8197682)
47. AC Wittgrove GW Clark KR Schubert 1996 Laparoscopic gastric bypass, Roux-en-Y: technique and results in 75 patients with 3-30 months follow-up Obes Surg 6 6 500 504 10.1381/096089296765556412 10729899 (Pubitemid 27032431)
48. NT Nguyen J Root K Zainabadi A Sabio S Chalifoux CM Stevens S Mavandadi M Longoria SE Wilson 2005 Accelerated growth of bariatric surgery with the introduction of minimally invasive surgery Arch Surg 140 12 1198 1202 10.1001/archsurg.140.12.1198 16365242 discussion 1203 (Pubitemid 41815903)
49. M Weber MK Muller T Bucher S Wildi D Dindo F Horber R Hauser PA Clavien 2004 Laparoscopic gastric bypass is superior to laparoscopic gastric banding for treatment of morbid obesity Ann Surg 240 6 975 982 15570203 discussion 982-973
50. P Marceau S Biron RA Bourque M Potvin FS Hould S Simard 1993 Biliopancreatic diversion with a new type of gastrectomy Obes Surg 3 1 29 35 10.1381/096089293765559728 10757900 (Pubitemid 23053420)
51. DS Hess DW Hess 1998 Biliopancreatic diversion with a duodenal switch Obes Surg 8 3 267 282 10.1381/096089298765554476 9678194 1:STN:280: DyaK1czktlWltw%3D%3D (Pubitemid 28334123)
52. JP Regan WB Inabnet M Gagner A Pomp 2003 Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient Obes Surg 13 6 861 864 10.1381/096089203322618669 14738671 1:STN:280:DC%2BD2c%2FjvF2rtw%3D%3D (Pubitemid 38010705)
53. D Cottam FG Qureshi SG Mattar S Sharma S Holover G Bonanomi R Ramanathan P Schauer 2006 Laparoscopic sleeve gastrectomy as an initial weight-loss procedure for high-risk patients with morbid obesity Surg Endosc 20 6 859 863 10.1007/s00464-005-0134-5 16738970 1:STN:280:DC%2BD28zisVegtg%3D%3D (Pubitemid 43825185)
54. FX Felberbauer F Langer S Shakeri-Manesch E Schmaldienst M Kees S Kriwanek M Prager G Prager 2008 Laparoscopic sleeve gastrectomy as an isolated bariatric procedure: intermediate-term results from a large series in three Austrian centers Obes Surg 18 7 814 818 10.1007/s11695-008-9483-1 18392898
55. N Scopinaro E Gianetta D Civalleri U Bonalumi V Bachi 1979 Bilio-pancreatic bypass for obesity: II. Initial experience in man Br J Surg 66 9 618 620 497645 1:STN:280:DyaL3c%2Fktlyqsw%3D%3D (Pubitemid 10224288)
56. P Marceau FS Hould S Simard S Lebel RA Bourque M Potvin S Biron 1998 Biliopancreatic diversion with duodenal switch World J Surg 22 9 947 954 9717420 1:STN:280:DyaK1czotlWnug%3D%3D (Pubitemid 28374612)
57. D Paiva L Bernardes L Suretti 2001 Laparoscopic biliopancreatic diversion for the treatment of morbid obesity: initial experience Obes Surg 11 5 619 622 10.1381/09608920160556832 11594106 1:STN:280:DC%2BD3MrkslOhug%3D%3D (Pubitemid 32907133)
58. JR Flores-Riveros JC McLenithan O Ezaki MD Lane 1993 Insulin down-regulates expression of the insulin-responsive glucose transporter (GLUT4) gene: effects on transcription and mRNA turnover Proc Natl Acad Sci U S A 90 2 512 516 8421683 1:CAS:528:DyaK3sXpsVOmsw%3D%3D (Pubitemid 23028893)
59. F Rubino M Gagner P Gentileschi S Kini S Fukuyama J Feng E Diamond 2004 The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism Ann Surg 240 2 236 242 15273546 (Pubitemid 38963013)
60. F Rubino J Marescaux 2004 Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease Ann Surg 239 1 1 11 10.1097/01.sla.0000102989.54824.fc 14685093 (Pubitemid 38176365)
61. F Rubino A Forgione DE Cummings M Vix D Gnuli G Mingrone M Castagneto J Marescaux 2006 The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes Ann Surg 244 5 741 749 10.1097/01.sla.0000224726.61448.1b 17060767 (Pubitemid 44629948)
62. F Rubino P Zizzari C Tomasetto MT Bluet-Pajot A Forgione M Vix D Grouselle J Marescaux 2005 The role of the small bowel in the regulation of circulating ghrelin levels and food intake in the obese Zucker rat Endocrinology 146 4 1745 1751 10.1210/en.2004-1181 15625244 1:CAS:528:DC%2BD2MXis1yqtLw%3D (Pubitemid 40396883)
63. F Rubino SL R'Bibo F del Genio M Mazumdar TE McGraw 2010 Metabolic surgery: the role of the gastrointestinal tract in diabetes mellitus Nat Rev Endocrinol 6 2 102 109 10.1038/nrendo.2009.268 20098450
64. F Rubino PR Schauer LM Kaplan DE Cummings 2010 Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action Annu Rev Med 61 393 411 10.1146/annurev.med.051308.105148 20059345 1:CAS:528:DC%2BC3cXisFylsbc%3D
65. L Rodriguez-Grunert MP Galvao Neto M Alamo AC Ramos PB Baez M Tarnoff 2008 First human experience with endoscopically delivered and retrieved duodenal-jejunal bypass sleeve Surg Obes Relat Dis 4 1 55 59 10.1016/j.soard.2007.07.012 18201671
66. M Tarnoff S Shikora A Lembo K Gersin 2008 Chronic in vivo experience with an endoscopically delivered and retrieved duodenal-jejunal bypass sleeve in a porcine model Surg Endosc 22 4 1023 1028 10.1007/s00464-007-9652-7 18030524 1:STN:280:DC%2BD1c3ksVCksQ%3D%3D
67. HS Koopmans A Sclafani 1981 Control of body weight by lower gut signals Int J Obes 5 5 491 495 7309331 1:STN:280:DyaL38%2FnsFSiuw%3D%3D (Pubitemid 11014636)
68. AL de Paula AL Macedo AS Prudente L Queiroz V Schraibman J Pinus 2006 Laparoscopic sleeve gastrectomy with ileal interposition ("neuroendocrine brake")-pilot study of a new operation Surg Obes Relat Dis 2 4 464 467 10.1016/j.soard.2006.03.005 16925382 (Pubitemid 44028838)
69. JJ Holst 2007 The physiology of glucagon-like peptide 1 Physiol Rev 87 4 1409 1439 10.1152/physrev.00034.2006 17928588 1:CAS:528:DC%2BD2sXhtlaqu7jI (Pubitemid 350041474)
70. R Nogueiras LM Williams C Dieguez 2010 Ghrelin: new molecular pathways modulating appetite and adiposity Obes Facts 3 5 285 292 10.1159/000321265 20975294 1:CAS:528:DC%2BC3cXhtlCqu7fM
71. JP Camina 2006 Cell biology of the ghrelin receptor J Neuroendocrinol 18 1 65 76 10.1111/j.1365-2826.2005.01379.x 16451222 1:CAS:528:DC%2BD28XhvFKmtLw%3D
72. C Gauna PJ Delhanty MO van Aken JA Janssen AP Themmen LJ Hofland M Culler F Broglio E Ghigo AJ van der Lely 2006 Unacylated ghrelin is active on the INS-1E rat insulinoma cell line independently of the growth hormone secretagogue receptor type 1a and the corticotropin releasing factor 2 receptor Mol Cell Endocrinol 251 1-2 103 111 10.1016/j.mce.2006.03.040 16647196 1:CAS:528:DC%2BD28XkvVyntb0%3D (Pubitemid 43728835)
73. DE Cummings 2009 Endocrine mechanisms mediating remission of diabetes after gastric bypass surgery Int J Obes (Lond) 33 1 S33 40 10.1038/ijo.2009.15 1:CAS:528:DC%2BD1MXksVamsLw%3D
74. G Fruhbeck A Diez Caballero MJ Gil 2004 Fundus functionality and ghrelin concentrations after bariatric surgery N Engl J Med 350 3 308 309 10.1056/NEJM200401153500323 14724316 (Pubitemid 38067650)
75. AJ van der Lely M Tschop ML Heiman E Ghigo 2004 Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin Endocr Rev 25 3 426 457 10.1210/er.2002-0029 15180951 (Pubitemid 38780667)
76. DE Cummings JQ Purnell RS Frayo K Schmidova BE Wisse DS Weigle 2001 A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans Diabetes 50 8 1714 1719 11473029 1:CAS:528:DC%2BD3MXlslKnurw%3D (Pubitemid 33641587)
77. DE Cummings RS Frayo C Marmonier R Aubert D Chapelot 2004 Plasma ghrelin levels and hunger scores in humans initiating meals voluntarily without time- and food-related cues Am J Physiol Endocrinol Metab 287 2 E297 304 10.1152/ajpendo.00582.2003 15039149 1:CAS:528:DC%2BD2cXmvVKntLo%3D (Pubitemid 38943896)
78. K Zwirska-Korczala SJ Konturek M Sodowski M Wylezol D Kuka P Sowa M Adamczyk-Sowa M Kukla A Berdowska JF Rehfeld W Bielanski T Brzozowski 2007 Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome J Physiol Pharmacol 58 Suppl 1 13 35 17443025 (Pubitemid 350022256)
79. DE Cummings J Overduin 2007 Gastrointestinal regulation of food intake J Clin Invest 117 1 13 23 10.1172/JCI30227 17200702 1:CAS:528: DC%2BD2sXmvV2rsg%3D%3D (Pubitemid 46048445)
80. A Asakawa A Inui T Kaga H Yuzuriha T Nagata N Ueno S Makino M Fujimiya A Niijima MA Fujino M Kasuga 2001 Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin Gastroenterology 120 2 337 345 11159873 1:CAS:528:DC%2BD3MXhtlKlt7Y%3D (Pubitemid 32149296)
81. M Arnold A Mura W Langhans N Geary 2006 Gut vagal afferents are not necessary for the eating-stimulatory effect of intraperitoneally injected ghrelin in the rat J Neurosci 26 43 11052 11060 10.1523/JNEUROSCI.2606-06.2006 17065447 1:CAS:528:DC%2BD28XhtFymsLnN (Pubitemid 44772195)
82. RP Vincent H Ashrafian CW le Roux 2008 Mechanisms of disease: the role of gastrointestinal hormones in appetite and obesity Nat Clin Pract Gastroenterol Hepatol 5 5 268 277 10.1038/ncpgasthep1118 18382432 1:CAS:528: DC%2BD1cXltlCksrg%3D (Pubitemid 351637912)
83. K Tymitz A Engel S McDonough MP Hendy G Kerlakian 2011 Changes in ghrelin levels following bariatric surgery: review of the literature Obes Surg 21 1 125 130 10.1007/s11695-010-0311-z 21104455
84. DE Cummings DS Weigle RS Frayo PA Breen MK Ma EP Dellinger JQ Purnell 2002 Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery N Engl J Med 346 21 1623 1630 10.1056/NEJMoa012908 12023994 (Pubitemid 34755670)
85. E Lin N Gletsu K Fugate D McClusky LH Gu JL Zhu BJ Ramshaw DA Papanicolaou TR Ziegler CD Smith 2004 The effects of gastric surgery on systemic ghrelin levels in the morbidly obese Arch Surg 139 7 780 784 10.1001/archsurg.139.7.780 15249413 (Pubitemid 38886515)
86. B Geloneze MA Tambascia VF Pilla SR Geloneze EM Repetto JC Pareja 2003 Ghrelin: a gut-brain hormone: effect of gastric bypass surgery Obes Surg 13 1 17 22 10.1381/096089203321136539 12630608 (Pubitemid 36250233)
87. JL Chan EC Mun V Stoyneva CS Mantzoros AB Goldfine 2006 Peptide YY levels are elevated after gastric bypass surgery Obesity (Silver Spring) 14 2 194 198 10.1038/oby.2006.25 1:CAS:528:DC%2BD28XlsVeksLc%3D (Pubitemid 46214749)
88. F Leonetti G Silecchia G Iacobellis MC Ribaudo A Zappaterreno C Tiberti CV Iannucci N Perrotta V Bacci MS Basso N Basso U Di Mario 2003 Different plasma ghrelin levels after laparoscopic gastric bypass and adjustable gastric banding in morbid obese subjects J Clin Endocrinol Metab 88 9 4227 4231 12970291 1:CAS:528:DC%2BD3sXntlagsr0%3D (Pubitemid 37153724)
89. G Fruhbeck F Rotellar JL Hernandez-Lizoain MJ Gil J Gomez-Ambrosi J Salvador JA Cienfuegos 2004 Fasting plasma ghrelin concentrations 6 months after gastric bypass are not determined by weight loss or changes in insulinemia Obes Surg 14 9 1208 1215 10.1381/0960892042386904 15527636 (Pubitemid 39458595)
90. R Morinigo R Casamitjana V Moize AM Lacy S Delgado R Gomis J Vidal 2004 Short-term effects of gastric bypass surgery on circulating ghrelin levels Obes Res 12 7 1108 1116 10.1038/oby.2004.139 15292475 (Pubitemid 41132490)
91. FB Langer MA Reza Hoda A Bohdjalian FX Felberbauer J Zacherl E Wenzl K Schindler A Luger B Ludvik G Prager 2005 Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels Obes Surg 15 7 1024 1029 10.1381/ 0960892054621125 16105401 1:STN:280:DC%2BD2MvjvFerug%3D%3D (Pubitemid 41116888)
92. SN Karamanakos K Vagenas F Kalfarentzos TK Alexandrides 2008 Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study Ann Surg 247 3 401 407 10.1097/SLA. 0b013e318156f012 18376181
93. EV Kotidis G Koliakos TS Papavramidis ST Papavramidis 2006 The effect of biliopancreatic diversion with pylorus-preserving sleeve gastrectomy and duodenal switch on fasting serum ghrelin, leptin and adiponectin levels: is there a hormonal contribution to the weight-reducing effect of this procedure? Obes Surg 16 5 554 559 10.1381/096089206776944940 16687021 (Pubitemid 43786076)
94. R Stoeckli R Chanda I Langer U Keller 2004 Changes of body weight and plasma ghrelin levels after gastric banding and gastric bypass Obes Res 12 2 346 350 10.1038/oby.2004.43 14981228 1:CAS:528:DC%2BD2cXislarurg%3D (Pubitemid 41132559)
95. K Schindler G Prager T Ballaban S Kretschmer R Riener B Buranyi C Maier A Luger B Ludvik 2004 Impact of laparoscopic adjustable gastric banding on plasma ghrelin, eating behaviour and body weight Eur J Clin Invest 34 8 549 554 10.1111/j.1365-2362.2004.01382.x 15305889 1:CAS:528:DC%2BD2cXnslOht78%3D (Pubitemid 39120224)
96. DG Haider K Schindler G Prager A Bohdjalian A Luger M Wolzt B Ludvik 2007 Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects J Clin Endocrinol Metab 92 3 1168 1171 10.1210/jc.2006-1839 17164313 1:CAS:528:DC%2BD2sXjtlGmsLY%3D (Pubitemid 46465698)
97. B Uzzan JM Catheline C Lagorce G Airinei C Bon R Cohen GY Perret T Aparicio R Benamouzig 2007 Expression of ghrelin in fundus is increased after gastric banding in morbidly obese patients Obes Surg 17 9 1159 1164 18074488 (Pubitemid 351321321)
98. M Faraj PJ Havel S Phelis D Blank AD Sniderman K Cianflone 2003 Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects J Clin Endocrinol Metab 88 4 1594 1602 12679444 1:CAS:528:DC%2BD3sXjtFClsL0%3D (Pubitemid 36623375)
99. C Holdstock BE Engstrom M Ohrvall L Lind M Sundbom FA Karlsson 2003 Ghrelin and adipose tissue regulatory peptides: effect of gastric bypass surgery in obese humans J Clin Endocrinol Metab 88 7 3177 3183 12843162 1:CAS:528:DC%2BD3sXlslait7s%3D (Pubitemid 36877491)
100. M Sundbom C Holdstock BE Engstrom FA Karlsson 2007 Early changes in ghrelin following Roux-en-Y gastric bypass: influence of vagal nerve functionality? Obes Surg 17 3 304 310 10.1007/s11695-007-9056-8 17546836 (Pubitemid 46659288)
101. BA Whitson DB Leslie TA Kellogg MA Maddaus H Buchwald CJ Billington S Ikramuddin 2007 Entero-endocrine changes after gastric bypass in diabetic and nondiabetic patients: a preliminary study J Surg Res 141 1 31 39 10.1016/j.jss.2007.02.022 17574036 1:CAS:528:DC%2BD2sXmsFCrt7s%3D (Pubitemid 46898439)
102. EV Kotidis GG Koliakos VG Baltzopoulos KN Ioannidis JG Yovos ST Papavramidis 2006 Serum ghrelin, leptin and adiponectin levels before and after weight loss: comparison of three methods of treatment-a prospective study Obes Surg 16 11 1425 1432 10.1381/096089206778870058 17132406 (Pubitemid 44759973)
103. D Foschi F Corsi F Colombo T Vago M Bevilaqua A Rizzi E Trabucchi 2008 Different effects of vertical banded gastroplasty and Roux-en-Y gastric bypass on meal inhibition of ghrelin secretion in morbidly obese patients J Invest Surg 21 2 77 81 10.1080/08941930701883624 18340624 1:STN:280:DC%2BD1c7otFWntw%3D%3D (Pubitemid 351404804)
104. D Foschi F Corsi A Rizzi E Asti V Carsenzuola T Vago M Bevilacqua P Riva E Trabucchi 2005 Vertical banded gastroplasty modifies plasma ghrelin secretion in obese patients Obes Surg 15 8 1129 1132 10.1381/0960892055002338 16197784 1:STN:280:DC%2BD2MrisFCisQ%3D%3D (Pubitemid 41390209)
105. C Stratis T Alexandrides K Vagenas F Kalfarentzos 2006 Ghrelin and peptide YY levels after a variant of biliopancreatic diversion with Roux-en-Y gastric bypass versus after colectomy: a prospective comparative study Obes Surg 16 6 752 758 10.1381/096089206777346772 16756737 (Pubitemid 43874832)
106. E Ram T Vishne D Diker I Gal-Ad R Maayan I Lerner Z Dreznik D Seror P Vardi A Weizman 2005 Impact of gastric banding on plasma ghrelin, growth hormone, cortisol, DHEA and DHEA-S levels Obes Surg 15 8 1118 1123 10.1381/0960892055002329 16197782 (Pubitemid 41390207)
107. ME Couce D Cottam J Esplen P Schauer B Burguera 2006 Is ghrelin the culprit for weight loss after gastric bypass surgery? A negative answer Obes Surg 16 7 870 878 10.1381/096089206777822151 16839485 (Pubitemid 44133475)
108. MC Mancini AP Costa ME de Melo C Cercato D Giannella-Neto AB Garrido Jr S Rosberg K Albertsson-Wikland SM Villares A Halpern 2006 Effect of gastric bypass on spontaneous growth hormone and ghrelin release profiles Obesity (Silver Spring) 14 3 383 387 10.1038/oby.2006.51 1:CAS:528:DC%2BD28XlsFKisb4%3D (Pubitemid 46219756)
109. CM Borg CW le Roux MA Ghatei SR Bloom AG Patel SJ Aylwin 2006 Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety Br J Surg 93 2 210 215 10.1002/bjs.5227 16392104 1:CAS:528:DC%2BD28XisF2gsrs%3D (Pubitemid 43259607)
110. JM Liou JT Lin WJ Lee HP Wang YC Lee HM Chiu MS Wu 2008 The serial changes of ghrelin and leptin levels and their relations to weight loss after laparoscopic minigastric bypass surgery Obes Surg 18 1 84 89 10.1007/s11695-007-9305-x 18080724
111. B Olivan J Teixeira M Bose B Bawa T Chang H Summe H Lee B Laferrere 2009 Effect of weight loss by diet or gastric bypass surgery on peptide YY3-36 levels Ann Surg 249 6 948 953 10.1097/SLA.0b013e3181a6cdb0 19474685
112. M Bose S Machineni B Olivan J Teixeira JJ McGinty B Bawa N Koshy A Colarusso B Laferrere 2010 Superior appetite hormone profile after equivalent weight loss by gastric bypass compared to gastric banding Obesity (Silver Spring) 18 6 1085 1091 10.1038/oby.2009.473 1:CAS:528:DC%2BC3cXmsVGqsrw%3D
113. J Korner W Inabnet G Febres IM Conwell DJ McMahon R Salas C Taveras B Schrope M Bessler 2009 Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass Int J Obes (Lond) 33 7 786 795 10.1038/ijo.2009.79 1:CAS:528:DC%2BD1MXoslOhu7Y%3D
114. A Baltasar C Serra N Perez R Bou M Bengochea L Ferri 2005 Laparoscopic sleeve gastrectomy: a multi-purpose bariatric operation Obes Surg 15 8 1124 1128 10.1381/0960892055002248 16197783 (Pubitemid 41390208)
115. T Akamizu T Shinomiya T Irako M Fukunaga Y Nakai K Kangawa 2005 Separate measurement of plasma levels of acylated and desacyl ghrelin in healthy subjects using a new direct ELISA assay J Clin Endocrinol Metab 90 1 6 9 10.1210/jc.2004-1640 15483072 1:CAS:528:DC%2BD2MXlvFensA%3D%3D (Pubitemid 40116625)
116. Peterli R, Wolnerhanssen B, Peters T, Devaux N, Kern B, Christoffel-Courtin C, Drewe J, von Flue M, Beglinger C (2009) Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial. Ann Surg 250(2):234-241. doi: 10.1097/SLA.0b013e3181ae32e3
117. Peterli R, Steinert RE, Woelnerhanssen B, Peters T, Christoffel-Courtin C, Gass M, Kern B, von Fluee M, Beglinger C (2011) Hormonal and metabolic implications of weight loss after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial (submitted)
118. A Bohdjalian FB Langer S Shakeri-Leidenmuhler L Gfrerer B Ludvik J Zacherl G Prager 2010 Sleeve gastrectomy as sole and definitive bariatric procedure: 5-year results for weight loss and ghrelin Obes Surg 20 5 535 540 10.1007/s11695-009-0066-6 20094819
119. R Vettor R Fabris C Pagano G Federspil 2002 Neuroendocrine regulation of eating behavior J Endocrinol Invest 25 10 836 854 12508946 1:CAS:528: DC%2BD3sXmsFOrsA%3D%3D (Pubitemid 35446351)
120. RJ Lieverse JB Jansen AA Masclee CB Lamers 1995 Satiety effects of a physiological dose of cholecystokinin in humans Gut 36 2 176 179 7883212 1:CAS:528:DyaK2MXksFamtrg%3D
121. BD Gaylinn MO Thorner 2010 Luminal influences to orchestrate gastroenterological hormone secretion: the fat, long-chain fatty acid, cholecystokinin, glucagon-like peptide 1 axis J Clin Endocrinol Metab 95 2 503 504 10.1210/jc.2009-2353 20133469 1:CAS:528:DC%2BC3cXitVaju70%3D
122. S Beglinger J Drewe J Schirra B Goke M D'Amato C Beglinger 2010 Role of fat hydrolysis in regulating glucagon-like peptide-1 secretion J Clin Endocrinol Metab 95 2 879 886 10.1210/jc.2009-1062 19837920 1:CAS:528:DC%2BC3cXitVaitr4%3D
123. JM Kellum JF Kuemmerle TM O'Dorisio P Rayford D Martin K Engle L Wolf HJ Sugerman 1990 Gastrointestinal hormone responses to meals before and after gastric bypass and vertical banded gastroplasty Ann Surg 211 6 763 770 2192696 1:STN:280:DyaK3c3ptVeiug%3D%3D discussion 770-761
124. D Foschi F Corsi L Pisoni T Vago M Bevilacqua E Asti I Righi E Trabucchi 2004 Plasma cholecystokinin levels after vertical banded gastroplasty: effects of an acidified meal Obes Surg 14 5 644 647 10.1381/096089204323093426 15186632 (Pubitemid 38716585)
125. YM Cho TJ Kieffer 2010 K-cells and glucose-dependent insulinotropic polypeptide in health and disease Vitam Horm 84 111 150 10.1016/B978-0-12- 381517-0.00004-7 21094898 1:CAS:528:DC%2BC3MXotlOktg%3D%3D
126. EG Siegel W Creutzfeldt 1985 Stimulation of insulin release in isolated rat islets by GIP in physiological concentrations and its relation to islet cyclic AMP content Diabetologia 28 11 857 861 2417905 1:CAS:528: DyaL28Xmt1Gksw%3D%3D (Pubitemid 16176057)
127. SA Ross J Dupre 1978 Effects of ingestion of triglyceride or galactose on secretion of gastric inhibitory polypeptide and on responses to intravenous glucose in normal and diabetic subjects Diabetes 27 3 327 333 640238 1:CAS:528:DyaE1cXhvVOntr4%3D (Pubitemid 8311752)
128. JA Ehses VR Casilla T Doty JA Pospisilik KD Winter HU Demuth RA Pederson CH McIntosh 2003 Glucose-dependent insulinotropic polypeptide promotes beta-(INS-1) cell survival via cyclic adenosine monophosphate-mediated caspase-3 inhibition and regulation of p38 mitogen-activated protein kinase Endocrinology 144 10 4433 4445 10.1210/en.2002-0068 12960055 1:CAS:528:DC%2BD3sXns1Srur4%3D (Pubitemid 37204843)
129. W Creutzfeldt 2001 The entero-insular axis in type 2 diabetes-incretins as therapeutic agents Exp Clin Endocrinol Diabetes 109 Suppl 2 S288 303 10.1055/s-2001-18589 11460578 1:CAS:528:DC%2BD3MXlslKgu74%3D (Pubitemid 32577588)
130. CI Cheeseman D O'Neill 1998 Basolateral d-glucose transport activity along the crypt-villus axis in rat jejunum and upregulation induced by gastric inhibitory peptide and glucagon-like peptide-2 Exp Physiol 83 5 605 616 9793781 1:CAS:528:DyaK1cXntFOnsrY%3D (Pubitemid 28458392)
131. D Elahi DK Andersen DC Muller JD Tobin JC Brown R Andres 1984 The enteric enhancement of glucose-stimulated insulin release. The role of GIP in aging, obesity, and non-insulin-dependent diabetes mellitus Diabetes 33 10 950 957 6383904 1:CAS:528:DyaL2cXlvV2hsr8%3D (Pubitemid 14013927)
132. T Vilsboll T Krarup J Sonne S Madsbad A Volund AG Juul JJ Holst 2003 Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus J Clin Endocrinol Metab 88 6 2706 2713 12788877 1:CAS:528:DC%2BD3sXkslCrs7s%3D (Pubitemid 36724446)
133. FK Knop T Vilsboll PV Hojberg S Larsen S Madsbad JJ Holst T Krarup 2007 The insulinotropic effect of GIP is impaired in patients with chronic pancreatitis and secondary diabetes mellitus as compared to patients with chronic pancreatitis and normal glucose tolerance Regul Pept 144 1-3 123 130 10.1016/j.regpep.2007.07.002 17692937 1:CAS:528:DC%2BD2sXht12gtbzE (Pubitemid 350030308)
134. FC Lynn N Pamir EH Ng CH McIntosh TJ Kieffer RA Pederson 2001 Defective glucose-dependent insulinotropic polypeptide receptor expression in diabetic fatty Zucker rats Diabetes 50 5 1004 1011 11334402 1:CAS:528: DC%2BD3MXkvFSgur8%3D (Pubitemid 32374530)
135. D Gniuli A Calcagno L Dalla Libera R Calvani L Leccesi ME Caristo R Vettor M Castagneto G Ghirlanda G Mingrone 2010 High-fat feeding stimulates endocrine, glucose-dependent insulinotropic polypeptide (GIP)-expressing cell hyperplasia in the duodenum of Wistar rats Diabetologia 53 10 2233 2240 10.1007/s00125-010-1830-9 20585935 1:CAS:528:DC%2BC3cXhtV2gtrbM
136. RS Rao S Kini 2011 GIP and bariatric surgery Obes Surg 21 2 244 252 10.1007/s11695-010-0305-x 21082290
137. J Korner M Bessler W Inabnet C Taveras JJ Holst 2007 Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding Surg Obes Relat Dis 3 6 597 601 10.1016/j.soard.2007.08.004 17936091 (Pubitemid 350091417)
138. B Laferrere S Heshka K Wang Y Khan J McGinty J Teixeira AB Hart B Olivan 2007 Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes Diabetes Care 30 7 1709 1716 10.2337/dc06-1549 17416796 1:CAS:528:DC%2BD2sXotlWhsbw%3D (Pubitemid 47036341)
139. B Laferrere J Teixeira J McGinty H Tran JR Egger A Colarusso B Kovack B Bawa N Koshy H Lee K Yapp B Olivan 2008 Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes J Clin Endocrinol Metab 93 7 2479 2485 10.1210/jc.2007-2851 18430778 1:CAS:528:DC%2BD1cXoslyktb8%3D (Pubitemid 352008510)
140. C Guidone M Manco E Valera-Mora A Iaconelli D Gniuli A Mari G Nanni M Castagneto M Calvani G Mingrone 2006 Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery Diabetes 55 7 2025 2031 10.2337/db06-0068 16804072 1:CAS:528:DC%2BD28XmvVChtL4%3D (Pubitemid 44509976)
141. G Mingrone G Nolfe GC Gissey A Iaconelli L Leccesi C Guidone G Nanni JJ Holst 2009 Circadian rhythms of GIP and GLP1 in glucose-tolerant and in type 2 diabetic patients after biliopancreatic diversion Diabetologia 52 5 873 881 10.1007/s00125-009-1288-9 19229515 1:CAS:528:DC%2BD1MXktVOrsb8%3D
142. S Salinari A Bertuzzi S Asnaghi C Guidone M Manco G Mingrone 2009 First-phase insulin secretion restoration and differential response to glucose load depending on the route of administration in type 2 diabetic subjects after bariatric surgery Diabetes Care 32 3 375 380 10.2337/dc08-1314 19033407 1:CAS:528:DC%2BD1MXjvVyqsbs%3D
143. JR Shak J Roper GI Perez-Perez CH Tseng F Francois Z Gamagaris C Patterson E Weinshel GA Fielding C Ren MJ Blaser 2008 The effect of laparoscopic gastric banding surgery on plasma levels of appetite-control, insulinotropic, and digestive hormones Obes Surg 18 9 1089 1096 10.1007/s11695-008-9454-6 18408980
144. AL DePaula AL Macedo V Schraibman BR Mota S Vencio 2009 Hormonal evaluation following laparoscopic treatment of type 2 diabetes mellitus patients with BMI 20-34 Surg Endosc 23 8 1724 1732 10.1007/s00464-008-0168-6 18830747
145. RV Cohen CA Schiavon JS Pinheiro JL Correa F Rubino 2007 Duodenal-jejunal bypass for the treatment of type 2 diabetes in patients with body mass index of 22-34 kg/m2: a report of 2 cases Surg Obes Relat Dis 3 2 195 197 10.1016/j.soard.2007.01.009 17386401 (Pubitemid 46444706)
146. HC Lee MK Kim HS Kwon E Kim KH Song 2010 Early changes in incretin secretion after laparoscopic duodenal-jejunal bypass surgery in type 2 diabetic patients Obes Surg 20 11 1530 1535 10.1007/s11695-010-0248-2 20803098
147. B Kreymann G Williams MA Ghatei SR Bloom 1987 Glucagon-like peptide-1 7-36: a physiological incretin in man Lancet 2 8571 1300 1304 2890903 1:CAS:528:DyaL1cXhs1Wrsbc%3D (Pubitemid 17156636)
148. AA Young BR Gedulin TJ Rink 1996 Dose-responses for the slowing of gastric emptying in a rodent model by glucagon-like peptide (7-36) NH2, amylin, cholecystokinin, and other possible regulators of nutrient uptake Metabolism 45 1 1 3 8544764 1:CAS:528:DyaK28Xkt1Siug%3D%3D (Pubitemid 26104260)
149. NM Neary CJ Small MR Druce AJ Park SM Ellis NM Semjonous CL Dakin K Filipsson F Wang AS Kent GS Frost MA Ghatei SR Bloom 2005 Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively Endocrinology 146 12 5120 5127 10.1210/en.2005-0237 16150917 1:CAS:528:DC%2BD2MXht1OgurzM (Pubitemid 41653025)
150. JM Egan AR Clocquet D Elahi 2002 The insulinotropic effect of acute exendin-4 administered to humans: comparison of nondiabetic state to type 2 diabetes J Clin Endocrinol Metab 87 3 1282 1290 11889200 1:CAS:528: DC%2BD38XitlWns7k%3D (Pubitemid 36121100)
151. OG Kolterman JB Buse MS Fineman E Gaines S Heintz TA Bicsak K Taylor D Kim M Aisporna Y Wang AD Baron 2003 Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes J Clin Endocrinol Metab 88 7 3082 3089 12843147 1:CAS:528:DC%2BD3sXlslaitr4%3D (Pubitemid 36877476)
152. RA DeFronzo RE Ratner J Han DD Kim MS Fineman AD Baron 2005 Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes Diabetes Care 28 5 1092 1100 15855572 1:CAS:528:DC%2BD2MXksF2hu7g%3D (Pubitemid 40616618)
153. I Raz M Hanefeld L Xu C Caria D Williams-Herman H Khatami 2006 Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus Diabetologia 49 11 2564 2571 10.1007/s00125-006-0416-z 17001471 1:CAS:528:DC%2BD28XhtFOqsrvF
154. BJ Goldstein MN Feinglos JK Lunceford J Johnson DE Williams-Herman 2007 Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin on glycemic control in patients with type 2 diabetes Diabetes Care 30 8 1979 1987 10.2337/dc07-0627 17485570 1:CAS:528: DC%2BD2sXpsleksr8%3D (Pubitemid 47219404)
155. MA Nauck G Meininger D Sheng L Terranella PP Stein 2007 Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial Diabetes Obes Metab 9 2 194 205 10.1111/j.1463-1326.2006.00704.x 17300595 1:CAS:528:DC%2BD2sXjs1SrtLw%3D (Pubitemid 46206563)
156. CW le Roux R Welbourn M Werling A Osborne A Kokkinos A Laurenius H Lonroth L Fandriks MA Ghatei SR Bloom T Olbers 2007 Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass Ann Surg 246 5 780 785 10.1097/SLA.0b013e3180caa3e3 17968169 (Pubitemid 350035654)
157. R Morinigo AM Lacy R Casamitjana S Delgado R Gomis J Vidal 2006 GLP-1 and changes in glucose tolerance following gastric bypass surgery in morbidly obese subjects Obes Surg 16 12 1594 1601 10.1381/096089206779319338 17217635 (Pubitemid 46032812)
158. I Valverde J Puente A Martin-Duce L Molina O Lozano V Sancho WJ Malaisse ML Villanueva-Penacarrillo 2005 Changes in glucagon-like peptide-1 (GLP-1) secretion after biliopancreatic diversion or vertical banded gastroplasty in obese subjects Obes Surg 15 3 387 397 10.1381/0960892053576613 15826475 (Pubitemid 40463608)
159. R Lugari A Dei Cas D Ugolotti AL Barilli C Camellini GC Ganzerla A Luciani B Salerni F Mittenperger S Nodari A Gnudi R Zandomeneghi 2004 Glucagon-like peptide 1 (GLP-1) secretion and plasma dipeptidyl peptidase IV (DPP-IV) activity in morbidly obese patients undergoing biliopancreatic diversion Horm Metab Res 36 2 111 115 10.1055/s-2004-814222 15002062 1:CAS:528:DC%2BD2cXislCjt7Y%3D (Pubitemid 38392252)
160. J Melissas M Daskalakis S Koukouraki I Askoxylakis M Metaxari E Dimitriadis M Stathaki JA Papadakis 2008 Sleeve gastrectomy-a "food limiting" operation Obes Surg 18 10 1251 1256 10.1007/s11695-008-9634-4 18663545
161. J Melissas S Koukouraki J Askoxylakis M Stathaki M Daskalakis K Perisinakis N Karkavitsas 2007 Sleeve gastrectomy: a restrictive procedure? Obes Surg 17 1 57 62 10.1007/s11695-007-9006-5 17355769
162. T Baumann S Kuesters J Grueneberger G Marjanovic L Zimmermann AO Schaefer UT Hopt M Langer WK Karcz 2011 Time-resolved MRI after ingestion of liquids reveals motility changes after laparoscopic sleeve gastrectomy-preliminary results Obes Surg 21 1 95 101 10.1007/s11695-010-0317-6 21088924
163. EJ Harvey K Arroyo J Korner WB Inabnet 2010 Hormone changes affecting energy homeostasis after metabolic surgery Mt Sinai J Med 77 5 446 465 10.1002/msj.20203 20960548
164. DR Gehlert 1998 Multiple receptors for the pancreatic polypeptide (PP-fold) family: physiological implications Proc Soc Exp Biol Med 218 1 7 22 9572148 1:CAS:528:DyaK1cXislGktrs%3D
165. TE Adrian GL Ferri AJ Bacarese-Hamilton HS Fuessl JM Polak SR Bloom 1985 Human distribution and release of a putative new gut hormone, peptide YY Gastroenterology 89 5 1070 1077 3840109 1:CAS:528:DyaL28XptFw%3D (Pubitemid 16231572)
166. X Deng PG Wood AF Sved DC Whitcomb 2001 The area postrema lesions alter the inhibitory effects of peripherally infused pancreatic polypeptide on pancreatic secretion Brain Res 902 1 18 29 11376591 1:CAS:528: DC%2BD3MXjslejurk%3D (Pubitemid 32497191)
167. R Mentlein P Dahms D Grandt R Kruger 1993 Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV Regul Pept 49 2 133 144 7907802 1:CAS:528:DyaK2cXks1GqtQ%3D%3D
168. RL Batterham MA Cowley CJ Small H Herzog MA Cohen CL Dakin AM Wren AE Brynes MJ Low MA Ghatei RD Cone SR Bloom 2002 Gut hormone PYY(3-36) physiologically inhibits food intake Nature 418 6898 650 654 10.1038/nature02666 12167864 1:CAS:528:DC%2BD38XlvVylt7s%3D
169. S Koda Y Date N Murakami T Shimbara T Hanada K Toshinai A Niijima M Furuya N Inomata K Osuye M Nakazato 2005 The role of the vagal nerve in peripheral PYY3-36-induced feeding reduction in rats Endocrinology 146 5 2369 2375 10.1210/en.2004-1266 15718279 1:CAS:528:DC%2BD2MXjslamtLc%3D (Pubitemid 40577525)
170. C Acuna-Goycolea AN van den Pol 2005 Peptide YY(3-36) inhibits both anorexigenic proopiomelanocortin and orexigenic neuropeptide Y neurons: implications for hypothalamic regulation of energy homeostasis J Neurosci 25 45 10510 10519 10.1523/JNEUROSCI.2552-05.2005 16280589 1:CAS:528:DC%2BD2MXht1KgtbvL (Pubitemid 41628453)
171. RP Vincent CW le Roux 2008 The satiety hormone peptide YY as a regulator of appetite J Clin Pathol 61 5 548 552 10.1136/jcp.2007.048488 18441153 1:CAS:528:DC%2BD1cXmvVyksrc%3D (Pubitemid 351678205)
172. CR Abbott M Monteiro CJ Small A Sajedi KL Smith JR Parkinson MA Ghatei SR Bloom 2005 The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway Brain Res 1044 1 127 131 10.1016/j.brainres.2005.03.011 15862798 1:CAS:528:DC%2BD2MXjvVOiu7s%3D (Pubitemid 40616060)
173. C Lavebratt A Alpman B Persson P Arner J Hoffstedt 2006 Common neuropeptide Y2 receptor gene variant is protective against obesity among Swedish men Int J Obes (Lond) 30 3 453 459 10.1038/sj.ijo.0803188 1:CAS:528:DC%2BD28Xhsl2htbg%3D
174. L Ma PA Tataranni RL Hanson AM Infante S Kobes C Bogardus LJ Baier 2005 Variations in peptide YY and Y2 receptor genes are associated with severe obesity in Pima Indian men Diabetes 54 5 1598 1602 15855352 1:CAS:528: DC%2BD2MXktVCktrY%3D (Pubitemid 40586696)
175. M Nematy JE O'Flynn L Wandrag AE Brynes SJ Brett M Patterson MA Ghatei SR Bloom GS Frost 2006 Changes in appetite related gut hormones in intensive care unit patients: a pilot cohort study Crit Care 10 1 R10 10.1186/cc3957 16420657 (Pubitemid 47079811)
176. RL Batterham MA Cohen SM Ellis CW Le Roux DJ Withers GS Frost MA Ghatei SR Bloom 2003 Inhibition of food intake in obese subjects by peptide YY3-36 N Engl J Med 349 10 941 948 10.1056/NEJMoa030204 12954742 1:CAS:528: DC%2BD3sXntFeitr8%3D (Pubitemid 37064767)
177. M Babu AK Purhonen T Bansiewicz K Makela J Walkowiak P Miettinen KH Herzig 2005 Effect of total colectomy and PYY infusion on food intake and body weight in rats Regul Pept 131 1-3 29 33 10.1016/j.regpep.2005.06.004 15996768 1:CAS:528:DC%2BD2MXhtVKjsr%2FJ (Pubitemid 41392988)
178. J Korner M Bessler LJ Cirilo IM Conwell A Daud NL Restuccia SL Wardlaw 2005 Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin J Clin Endocrinol Metab 90 1 359 365 10.1210/jc.2004-1076 15483088 1:CAS:528: DC%2BD2MXlvFequw%3D%3D (Pubitemid 40116682)
179. E Naslund P Gryback PM Hellstrom H Jacobsson JJ Holst E Theodorsson L Backman 1997 Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass for massive obesity Int J Obes Relat Metab Disord 21 5 387 392 9152741 1:STN:280:DyaK2s3pslaksA%3D%3D (Pubitemid 27190191)
180. RL Batterham SR Bloom 2003 The gut hormone peptide YY regulates appetite Ann N Y Acad Sci 994 162 168 12851312 1:CAS:528:DC%2BD3sXmtVCkt7w%3D (Pubitemid 36793863)
181. RL Batterham H Heffron S Kapoor JE Chivers K Chandarana H Herzog CW Le Roux EL Thomas JD Bell DJ Withers 2006 Critical role for peptide YY in protein-mediated satiation and body-weight regulation Cell Metab 4 3 223 233 10.1016/j.cmet.2006.08.001 16950139 1:CAS:528:DC%2BD28XpvFajs78%3D (Pubitemid 44307976)
182. PK Chelikani AC Haver JR Reeve Jr DA Keire RD Reidelberger 2006 Daily, intermittent intravenous infusion of peptide YY(3-36) reduces daily food intake and adiposity in rats Am J Physiol Regul Integr Comp Physiol 290 2 R298 305 10.1152/ajpregu.00674.2005 16210414 1:CAS:528:DC%2BD28XhsFKisbw%3D
183. CW le Roux RL Batterham SJ Aylwin M Patterson CM Borg KJ Wynne A Kent RP Vincent J Gardiner MA Ghatei SR Bloom 2006 Attenuated peptide YY release in obese subjects is associated with reduced satiety Endocrinology 147 1 3 8 10.1210/en.2005-0972 16166213 (Pubitemid 43004254)
184. D Renshaw RL Batterham 2005 Peptide YY: a potential therapy for obesity Curr Drug Targets 6 2 171 179 15777187 1:CAS:528:DC%2BD2MXisVSqurk%3D (Pubitemid 40394312)
185. L Degen S Oesch M Casanova S Graf S Ketterer J Drewe C Beglinger 2005 Effect of peptide YY3-36 on food intake in humans Gastroenterology 129 5 1430 1436 10.1053/j.gastro.2005.09.001 16285944 1:CAS:528:DC%2BD2MXht12hu7fF (Pubitemid 41597385)
186. JP Valderas V Irribarra C Boza R de la Cruz Y Liberona AM Acosta M Yolito A Maiz 2010 Medical and surgical treatments for obesity have opposite effects on peptide YY and appetite: a prospective study controlled for weight loss J Clin Endocrinol Metab 95 3 1069 1075 10.1210/jc.2009-0983 20097707 1:CAS:528:DC%2BC3cXjs1Kqsb0%3D
187. AM Ingalls MM Dickie GD Snell 1950 Obese, a new mutation in the house mouse J Hered 41 12 317 318 14824537 1:STN:280:DyaG3M%2FlsVSrtQ%3D%3D
188. Y Zhang R Proenca M Maffei M Barone L Leopold JM Friedman 1994 Positional cloning of the mouse obese gene and its human homologue Nature 372 6505 425 432 10.1038/372425a0 7984236 1:CAS:528:DyaK2MXisVGqsbs%3D (Pubitemid 24365442)
189. KW Williams MM Scott JK Elmquist 2009 From observation to experimentation: leptin action in the mediobasal hypothalamus Am J Clin Nutr 89 3 985S 990S 10.3945/ajcn.2008.26788D 19176744 1:CAS:528:DC%2BD1MXjtFGksr8%3D
190. C Chin-Chance KS Polonsky DA Schoeller 2000 Twenty-four-hour leptin levels respond to cumulative short-term energy imbalance and predict subsequent intake J Clin Endocrinol Metab 85 8 2685 2691 10946866 1:CAS:528: DC%2BD3cXnslaiu7o%3D (Pubitemid 32269136)
191. JM Friedman JL Halaas 1998 Leptin and the regulation of body weight in mammals Nature 395 6704 763 770 10.1038/27376 9796811 1:CAS:528: DyaK1cXmvFOmsL0%3D (Pubitemid 28485436)
192. A Bado S Levasseur S Attoub S Kermorgant JP Laigneau MN Bortoluzzi L Moizo T Lehy M Guerre-Millo Y Le Marchand-Brustel MJ Lewin 1998 The stomach is a source of leptin Nature 394 6695 790 793 10.1038/29547 9723619 1:CAS:528:DyaK1cXlslemsbo%3D (Pubitemid 28391644)
193. P Ducy M Amling S Takeda M Priemel AF Schilling FT Beil J Shen C Vinson JM Rueger G Karsenty 2000 Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass Cell 100 2 197 207 10660043 1:CAS:528:DC%2BD3cXotFChsw%3D%3D (Pubitemid 30064908)
194. JL Chan K Heist AM DePaoli JD Veldhuis CS Mantzoros 2003 The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men J Clin Invest 111 9 1409 1421 10.1172/JCI17490 12727933 1:CAS:528:DC%2BD3sXjsFCrs70%3D (Pubitemid 36554712)
195. KL Knutson K Spiegel P Penev E Van Cauter 2007 The metabolic consequences of sleep deprivation Sleep Med Rev 11 3 163 178 10.1016/j.smrv.2007.01.002 17442599 (Pubitemid 46778995)
196. R Otsuka H Yatsuya K Tamakoshi K Matsushita K Wada H Toyoshima 2006 Perceived psychological stress and serum leptin concentrations in Japanese men Obesity (Silver Spring) 14 10 1832 1838 10.1038/oby.2006.211 1:CAS:528:DC%2BD28Xht1ehtbnF (Pubitemid 46214807)
197. RS Ahima JS Flier 2000 Leptin Annu Rev Physiol 62 413 437 10.1146/annurev.physiol.62.1.413 10845097 1:CAS:528:DC%2BD3cXltlGrsbs%3D (Pubitemid 30618269)
198. ZT Bloomgarden 2006 Gut and adipocyte peptides Diabetes Care 29 2 450 456 16443906 1:CAS:528:DC%2BD28Xhs1Kiurc%3D (Pubitemid 44106537)
199. WS Dhillo 2007 Appetite regulation: an overview Thyroid 17 5 433 445 10.1089/thy.2007.0018 17542673 1:CAS:528:DC%2BD2sXmtVSlsr0%3D (Pubitemid 46878846)
200. A Oswal G Yeo 2010 Leptin and the control of body weight: a review of its diverse central targets, signaling mechanisms, and role in the pathogenesis of obesity Obesity (Silver Spring) 18 2 221 229 10.1038/oby.2009.228
201. WA Banks SA Farr JE Morley 2006 The effects of high fat diets on the blood-brain barrier transport of leptin: failure or adaptation? Physiol Behav 88 3 244 248 10.1016/j.physbeh.2006.05.037 16781741 1:CAS:528:DC%2BD28Xmt1Oqtrg%3D
202. T Morioka E Asilmaz J Hu JF Dishinger AJ Kurpad CF Elias H Li JK Elmquist RT Kennedy RN Kulkarni 2007 Disruption of leptin receptor expression in the pancreas directly affects beta cell growth and function in mice J Clin Invest 117 10 2860 2868 10.1172/JCI30910 17909627 1:CAS:528:DC%2BD2sXhtFCnt73F (Pubitemid 47529616)
203. S Boghossian MG Dube R Torto PS Kalra SP Kalra 2006 Hypothalamic clamp on insulin release by leptin-transgene expression Peptides 27 12 3245 3254 10.1016/j.peptides.2006.07.022 16962683 1:CAS:528:DC%2BD28Xht1Cisr%2FO (Pubitemid 44738167)
204. LM Beckman TR Beckman CP Earthman 2010 Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass procedure: a review J Am Diet Assoc 110 4 571 584 10.1016/j.jada.2009.12.023 20338283 1:CAS:528: DC%2BC3cXls12lsr4%3D
205. M Riedl G Vila C Maier A Handisurya S Shakeri-Manesch G Prager O Wagner A Kautzky-Willer B Ludvik M Clodi A Luger 2008 Plasma osteopontin increases after bariatric surgery and correlates with markers of bone turnover but not with insulin resistance J Clin Endocrinol Metab 93 6 2307 2312 10.1210/jc.2007-2383 18334587 1:CAS:528:DC%2BD1cXntFamtb4%3D (Pubitemid 351831552)
206. CA Meier E Bobbioni C Gabay F Assimacopoulos-Jeannet A Golay JM Dayer 2002 IL-1 receptor antagonist serum levels are increased in human obesity: a possible link to the resistance to leptin? J Clin Endocrinol Metab 87 3 1184 1188 11889184 1:CAS:528:DC%2BD38XitlWguro%3D (Pubitemid 36121085)
207. J Korner W Inabnet IM Conwell C Taveras A Daud L Olivero-Rivera NL Restuccia M Bessler 2006 Differential effects of gastric bypass and banding on circulating gut hormone and leptin levels Obesity (Silver Spring) 14 9 1553 1561 10.1038/oby.2006.179 1:CAS:528:DC%2BD28Xht1WjsLzP (Pubitemid 46214822)
208. AB Goldfine EC Mun E Devine R Bernier M Baz-Hecht DB Jones BE Schneider JJ Holst ME Patti 2007 Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal J Clin Endocrinol Metab 92 12 4678 4685 10.1210/jc.2007-0918 17895322 1:CAS:528:DC%2BD1cXmslWhurY%3D (Pubitemid 350223444)
209. R Stockli U Keller 2003 Effectiveness of therapeutic interventions in obesity Praxis (Bern 1994) 92 47 1999 2006 1:STN:280:DC%2BD3srovVGqtQ%3D%3D
210. MS Hickey WJ Pories KG MacDonald Jr KA Cory GL Dohm MS Swanson RG Israel HA Barakat RV Considine JF Caro JA Houmard 1998 A new paradigm for type 2 diabetes mellitus: could it be a disease of the foregut? Ann Surg 227 5 637 643 9605655 1:STN:280:DyaK1c3ms1KqsA%3D%3D discussion 643-634
211. G Fruhbeck A Diez-Caballero MJ Gil I Montero J Gomez-Ambrosi J Salvador JA Cienfuegos 2004 The decrease in plasma ghrelin concentrations following bariatric surgery depends on the functional integrity of the fundus Obes Surg 14 5 606 612 10.1381/096089204323093363 15186626 (Pubitemid 38716579)
212. Woelnerhanssen B, Peterli R, Steinert RE, Peters T, Borbely Y, Beglinger C (2011) Effects of postbariatric surgery weight loss on adipokines and metabolic parameters: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy-a prospective randomized trial. Surg Obes Relat Dis. doi: 10.1016/j.soard.2011.01.044
213. J Nijhuis FM Van Dielen WA Buurman JW Greve 2004 Leptin in morbidly obese patients: no role for treatment of morbid obesity but important in the postoperative immune response Obes Surg 14 4 476 483 10.1381/096089204323013451 15130222 (Pubitemid 38570285)
214. JJ Hillebrand N Geary 2010 Do leptin and insulin signal adiposity? Forum Nutr 63 111 122 10.1159/000264399 19955779 1:CAS:528:DC%2BC3cXjslant7w%3D
215. PS MacLean JA Higgins MR Jackman GC Johnson BK Fleming-Elder HR Wyatt EL Melanson JO Hill 2006 Peripheral metabolic responses to prolonged weight reduction that promote rapid, efficient regain in obesity-prone rats Am J Physiol Regul Integr Comp Physiol 290 6 R1577 1588 10.1152/ajpregu.00810.2005 16455763 1:CAS:528:DC%2BD28XlvVeku70%3D (Pubitemid 43830823)
216. PE Scherer S Williams M Fogliano G Baldini HF Lodish 1995 A novel serum protein similar to C1q, produced exclusively in adipocytes J Biol Chem 270 45 26746 26749 7592907 1:CAS:528:DyaK2MXpsVGmurY%3D
217. K Hotta T Funahashi NL Bodkin HK Ortmeyer Y Arita BC Hansen Y Matsuzawa 2001 Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys Diabetes 50 5 1126 1133 11334417 1:CAS:528:DC%2BD3MXkvFSgu7g%3D (Pubitemid 32374544)
218. O Ukkola M Santaniemi 2002 Adiponectin: a link between excess adiposity and associated comorbidities? J Mol Med 80 11 696 702 10.1007/s00109-002-0378-7 12436346 1:CAS:528:DC%2BD38XoslOrsrs%3D (Pubitemid 35352035)
219. N Vilarrasa J Vendrell R Sanchez-Santos M Broch A Megia C Masdevall N Gomez J Soler J Pujol C Bettonica H Aranda JM Gomez 2007 Effect of weight loss induced by gastric bypass on proinflammatory interleukin-18, soluble tumour necrosis factor-alpha receptors, C-reactive protein and adiponectin in morbidly obese patients Clin Endocrinol (Oxf) 67 5 679 686 10.1111/j.1365-2265.2007. 02945.x 1:CAS:528:DC%2BD2sXhtlOhs7zL (Pubitemid 47628468)
220. C Weyer T Funahashi S Tanaka K Hotta Y Matsuzawa RE Pratley PA Tataranni 2001 Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia J Clin Endocrinol Metab 86 5 1930 1935 11344187 1:CAS:528:DC%2BD3MXjs1OmsL0%3D (Pubitemid 32472900)
221. AJ Hanley D Bowden LE Wagenknecht A Balasubramanyam C Langfeld MF Saad JI Rotter X Guo YD Chen M Bryer-Ash JM Norris SM Haffner 2007 Associations of adiponectin with body fat distribution and insulin sensitivity in nondiabetic Hispanics and African-Americans J Clin Endocrinol Metab 92 7 2665 2671 10.1210/jc.2006-2614 17426091 1:CAS:528:DC%2BD2sXotVylsbg%3D (Pubitemid 47037374)
222. A Coppola R Marfella L Coppola E Tagliamonte D Fontana E Liguori T Cirillo M Cafiero S Natale C Astarita 2009 Effect of weight loss on coronary circulation and adiponectin levels in obese women Int J Cardiol 134 3 414 416 10.1016/j.ijcard.2007.12.087 18378021
223. N Kubota Y Terauchi T Kubota H Kumagai S Itoh H Satoh W Yano H Ogata K Tokuyama I Takamoto T Mineyama M Ishikawa M Moroi K Sugi T Yamauchi K Ueki K Tobe T Noda R Nagai T Kadowaki 2006 Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and -independent pathways J Biol Chem 281 13 8748 8755 10.1074/jbc.M505649200 16431926 1:CAS:528:DC%2BD28XivVCns7s%3D (Pubitemid 43847980)
224. KL Butner SM Nickols-Richardson SF Clark WK Ramp WG Herbert 2010 A review of weight loss following Roux-en-Y gastric bypass vs restrictive bariatric surgery: impact on adiponectin and insulin Obes Surg 20 5 559 568 10.1007/s11695-010-0089-z 20177811
225. E Lin LS Phillips TR Ziegler B Schmotzer K Wu LH Gu L Khaitan SA Lynch WE Torres CD Smith N Gletsu-Miller 2007 Increases in adiponectin predict improved liver, but not peripheral, insulin sensitivity in severely obese women during weight loss Diabetes 56 3 735 742 10.2337/db06-1161 17327444 1:CAS:528:DC%2BD2sXis12itL0%3D (Pubitemid 46348478)
226. J Vendrell M Broch N Vilarrasa A Molina JM Gomez C Gutierrez I Simon J Soler C Richart 2004 Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity Obes Res 12 6 962 971 10.1038/oby.2004.118 15229336 1:CAS:528:DC%2BD2cXmtlSlsbw%3D
227. A Serra ML Granada R Romero B Bayes A Canton J Bonet M Rull A Alastrue X Formiguera 2006 The effect of bariatric surgery on adipocytokines, renal parameters and other cardiovascular risk factors in severe and very severe obesity: 1-year follow-up Clin Nutr 25 3 400 408 10.1016/j.clnu.2005.11.014 16709438 1:CAS:528:DC%2BD28XlsFKks7c%3D (Pubitemid 44182760)
228. CC Coughlin BN Finck JC Eagon VJ Halpin F Magkos BS Mohammed S Klein 2007 Effect of marked weight loss on adiponectin gene expression and plasma concentrations Obesity (Silver Spring) 15 3 640 645 10.1038/oby.2007.556 1:CAS:528:DC%2BD2sXksVCksL8%3D (Pubitemid 46643317)
229. CP de Carvalho DM Marin AL de Souza JC Pareja EA Chaim MS de Barros CA da Silva B Geloneze E Muscelli SM Alegre 2009 GLP-1 and adiponectin: effect of weight loss after dietary restriction and gastric bypass in morbidly obese patients with normal and abnormal glucose metabolism Obes Surg 19 3 313 320 10.1007/s11695-008-9678-5 18815849
230. N Garcia de la Torre MA Rubio E Bordiu L Cabrerizo E Aparicio C Hernandez A Sanchez-Pernaute L Diez-Valladares AJ Torres M Puente AL Charro 2008 Effects of weight loss after bariatric surgery for morbid obesity on vascular endothelial growth factor-A, adipocytokines, and insulin J Clin Endocrinol Metab 93 11 4276 4281 10.1210/jc.2007-1370 18713823 1:CAS:528:DC%2BD1cXhtlyqs7nK (Pubitemid 352789522)
231. MA Trakhtenbroit JG Leichman MF Algahim CC Miller 3rd FG Moody TR Lux H Taegtmeyer 2009 Body weight, insulin resistance, and serum adipokine levels 2 years after 2 types of bariatric surgery Am J Med 122 5 435 442 10.1016/j.amjmed.2008.10.035 19375553 1:CAS:528:DC%2BD1MXkslGlt7w%3D
232. MM Swarbrick IT Austrheim-Smith KL Stanhope MD Van Loan MR Ali BM Wolfe PJ Havel 2006 Circulating concentrations of high-molecular-weight adiponectin are increased following Roux-en-Y gastric bypass surgery Diabetologia 49 11 2552 2558 10.1007/s00125-006-0452-8 17019599 1:CAS:528:DC%2BD28XhtFOqsrvJ (Pubitemid 44559522)
233. BA Whitson DB Leslie TA Kellogg MA Maddaus H Buchwald CJ Billington S Ikramuddin 2007 Adipokine response in diabetics and nondiabetics following the Roux-en-Y gastric bypass: a preliminary study J Surg Res 142 2 295 300 10.1016/j.jss.2007.03.036 17640666 1:CAS:528:DC%2BD2sXhtVOgs7bN (Pubitemid 47418830)
234. D Diker T Vishne R Maayan A Weizman P Vardi Z Dreznik D Seror E Ram 2006 Impact of gastric banding on plasma adiponectin levels Obes Surg 16 8 1057 1061 10.1381/096089206778026244 16901360 (Pubitemid 44221272)
235. DG Haider K Schindler G Schaller G Prager M Wolzt B Ludvik 2006 Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding J Clin Endocrinol Metab 91 4 1578 1581 10.1210/jc.2005-2248 16449335 1:CAS:528:DC%2BD28XjvFOktLk%3D
236. J Engl T Bobbert C Ciardi M Laimer T Tatarczyk S Kaser H Weiss C Molnar H Tilg JR Patsch J Spranger CF Ebenbichler 2007 Effects of pronounced weight loss on adiponectin oligomer composition and metabolic parameters Obesity (Silver Spring) 15 5 1172 1178 10.1038/oby.2007.627 1:CAS:528:DC%2BD2sXmsFyltbc%3D (Pubitemid 46932472)
237. C Poitou JM Lacorte M Coupaye S Bertrais JF Bedel N Lafon JL Bouillot P Galan F Borson-Chazot A Basdevant C Coussieu K Clement 2005 Relationship between single nucleotide polymorphisms in leptin, IL6 and adiponectin genes and their circulating product in morbidly obese subjects before and after gastric banding surgery Obes Surg 15 1 11 23 10.1381/0960892052993431 15760495 (Pubitemid 40203820)
238. HP Kopp K Krzyzanowska M Mohlig J Spranger AF Pfeiffer G Schernthaner 2005 Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women Int J Obes (Lond) 29 7 766 771 10.1038/sj.ijo.0802983 1:CAS:528: DC%2BD2MXkvV2ntrY%3D (Pubitemid 40897012)
239. X Zhang DC Yeung M Karpisek D Stejskal ZG Zhou F Liu RL Wong WS Chow AW Tso KS Lam A Xu 2008 Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans Diabetes 57 5 1246 1253 10.2337/db07-1476 18252893 1:CAS:528:DC%2BD1cXlvVKjtL4%3D
240. A Handisurya M Riedl G Vila C Maier M Clodi T Prikoszovich B Ludvik G Prager A Luger A Kautzky-Willer 2010 Serum vaspin concentrations in relation to insulin sensitivity following RYGB-induced weight loss Obes Surg 20 2 198 203 10.1007/s11695-009-9882-y 19506980
241. P Lefebvre B Cariou F Lien F Kuipers B Staels 2009 Role of bile acids and bile acid receptors in metabolic regulation Physiol Rev 89 1 147 191 10.1152/physrev.00010.2008 19126757 1:CAS:528:DC%2BD1MXit1Cqtro%3D
242. M Watanabe SM Houten C Mataki MA Christoffolete BW Kim H Sato N Messaddeq JW Harney O Ezaki T Kodama K Schoonjans AC Bianco J Auwerx 2006 Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation Nature 439 7075 484 489 10.1038/nature04330 16400329 1:CAS:528: DC%2BD28XntFWmuw%3D%3D (Pubitemid 43152840)
243. O Shaham R Wei TJ Wang C Ricciardi GD Lewis RS Vasan SA Carr R Thadhani RE Gerszten VK Mootha 2008 Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity Mol Syst Biol 4 214 10.1038/msb.2008.50 18682704
244. H Nakatani K Kasama T Oshiro M Watanabe H Hirose H Itoh 2009 Serum bile acid along with plasma incretins and serum high-molecular weight adiponectin levels are increased after bariatric surgery Metabolism 58 10 1400 1407 10.1016/j.metabol.2009.05.006 19570554 1:CAS:528:DC%2BD1MXhtFGqt7nP
245. VA Fonseca J Rosenstock AC Wang KE Truitt MR Jones 2008 Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy Diabetes Care 31 8 1479 1484 10.2337/dc08-0283 18458145 1:CAS:528:DC%2BD1cXhtVWlur3E
246. RB Goldberg VA Fonseca KE Truitt MR Jones 2008 Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy Arch Intern Med 168 14 1531 1540 10.1001/archinte.168.14.1531 18663165 1:CAS:528:DC%2BD1cXpvFKjsLc%3D
247. T Yamakawa T Takano H Utsunomiya K Kadonosono A Okamura 2007 Effect of colestimide therapy for glycemic control in type 2 diabetes mellitus with hypercholesterolemia Endocr J 54 1 53 58 17102570 1:CAS:528:DC%2BD2sXlsVynt78%3D (Pubitemid 46481671)
248. M Kobayashi H Ikegami T Fujisawa K Nojima Y Kawabata S Noso N Babaya M Itoi-Babaya K Yamaji Y Hiromine M Shibata T Ogihara 2007 Prevention and treatment of obesity, insulin resistance, and diabetes by bile acid-binding resin Diabetes 56 1 239 247 10.2337/db06-0353 17192488 1:CAS:528: DC%2BD2sXhtVWltLo%3D
249. J Wei K de Qiu X Ma 2009 Bile acids and insulin resistance: implications for treating nonalcoholic fatty liver disease J Dig Dis 10 2 85 90 10.1111/j.1751-2980.2009.00369.x 19426389 1:CAS:528:DC%2BD1MXmvFejsL4%3D
250. Pols TW, Noriega LG, Nomura M, Auwerx J, Schoonjans K (2010) The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation. J Hepatol. doi: 10.1016/j.jhep.2010.12.004
251. JI Yang JH Yoon SJ Myung GY Gwak W Kim GE Chung SH Lee SM Lee CY Kim HS Lee 2007 Bile acid-induced TGR5-dependent c-Jun-N terminal kinase activation leads to enhanced caspase 8 activation in hepatocytes Biochem Biophys Res Commun 361 1 156 161 10.1016/j.bbrc.2007.07.001 17659258 1:CAS:528: DC%2BD2sXotlWrtLc%3D (Pubitemid 47102281)
252. H Yasuda S Hirata K Inoue H Mashima H Ohnishi M Yoshiba 2007 Involvement of membrane-type bile acid receptor M-BAR/TGR5 in bile acid-induced activation of epidermal growth factor receptor and mitogen-activated protein kinases in gastric carcinoma cells Biochem Biophys Res Commun 354 1 154 159 10.1016/j.bbrc.2006.12.168 17214962 1:CAS:528:DC%2BD2sXhtVClsr8%3D (Pubitemid 46131451)
253. S Katsuma A Hirasawa G Tsujimoto 2005 Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1 Biochem Biophys Res Commun 329 1 386 390 10.1016/j.bbrc.2005.01.139 15721318 1:CAS:528:DC%2BD2MXhsFSisbo%3D (Pubitemid 40255465)
254. C Thomas J Auwerx K Schoonjans 2008 Bile acids and the membrane bile acid receptor TGR5-connecting nutrition and metabolism Thyroid 18 2 167 174 10.1089/thy.2007.0255 18279017 1:CAS:528:DC%2BD1cXitVKntLw%3D (Pubitemid 351271532)
255. A Gastaldelli A Natali R Vettor SG Corradini 2010 Insulin resistance, adipose depots and gut: interactions and pathological implications Dig Liver Dis 42 5 310 319 10.1016/j.dld.2010.01.013 20194050 1:CAS:528:DC%2BC3cXotVejt74%3D
256. B Angelin K Einarsson K Hellstrom 1976 Evidence for the absorption of bile acids in the proximal small intestine of normo- and hyperlipidaemic subjects Gut 17 6 420 425 182622 1:CAS:528:DyaE28XltVOit7c%3D
257. AT Stearns A Balakrishnan DB Rhoads A Tavakkolizadeh 2010 Rapid upregulation of sodium-glucose transporter SGLT1 in response to intestinal sweet taste stimulation Ann Surg 251 5 865 871 10.1097/SLA.0b013e3181d96e1f 20395849
258. Gerspach AC, Steinert RE, Schonenberger L, Graber-Maier A, Beglinger C (2011) The role of the gut sweet taste receptor in regulating GLP-1. PYY and CCK release in humans. Am J Physiol Endocrinol Metab. doi: 10.1152/ajpendo.00077. 2011
259. Steinert RE, Gerspach AC, Gutmann H, Asarian L, Drewe J, Beglinger C (2011) The functional involvement of gut-expressed sweet taste receptors in glucose-stimulated secretion of glucagon-like peptide-1 (GLP-1) and peptide YY (PYY). Clin Nutr. doi: 10.1016/j.clnu.2011.01.007
260. AL DePaula AL Macedo N Rassi CA Machado V Schraibman LQ Silva A Halpern 2008 Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35 Surg Endosc 22 3 706 716 10.1007/s00464-007-9472-9 17704886 1:STN:280:DC%2BD1c7lsFeqsg%3D%3D (Pubitemid 351341683)
261. WB Inabnet 2010 Comment on: prospective randomized controlled trial comparing 2 versions of laparoscopic ileal interposition associated with sleeve gastrectomy for patients with type 2 diabetes with BMI 21-34 kg/m(2) Surg Obes Relat Dis 6 3 304 305 10.1016/j.soard.2009.11.005 20189466
262. GS Ferzli E Dominique M Ciaglia MH Bluth A Gonzalez A Fingerhut 2009 Clinical improvement after duodenojejunal bypass for nonobese type 2 diabetes despite minimal improvement in glycemic homeostasis World J Surg 33 5 972 979 10.1007/s00268-009-9968-7 19288284 1:STN:280:DC%2BD1M3oslOntg%3D%3D
263. N Scopinaro F Papadia G Camerini G Marinari D Civalleri A Gian Franco 2008 A comparison of a personal series of biliopancreatic diversion and literature data on gastric bypass help to explain the mechanisms of resolution of type 2 diabetes by the two operations Obes Surg 18 8 1035 1038 10.1007/s11695-008-9531-x 18463931
264. N Scopinaro GF Adami FS Papadia G Camerini F Carlini M Fried L Briatore G D'Alessandro G Andraghetti R Cordera 2011 Effects of biliopanceratic diversion on type 2 diabetes in patients with BMI 25 to 35 Ann Surg 253 4 699 703 10.1097/SLA.0b013e318203ae44 21475009
265. Scopinaro N, Adami GF, Papadia FS, Camerini G, Carlini F, Briatore L, D'Alessandro G, Parodi C, Weiss A, Andraghetti G, Catalano M, Cordera R (2011) The effects of biliopancreatic diversion on type 2 diabetes mellitus in patients with mild obesity (BMI 30-35 kg/m(2)) and simple overweight (BMI 25-30 kg/m (2)): a prospective controlled study. Obes Surg. doi: 10.1007/s11695-011-0407-0
266. PR Schauer B Burguera S Ikramuddin D Cottam W Gourash G Hamad GM Eid S Mattar R Ramanathan E Barinas-Mitchel RH Rao L Kuller D Kelley 2003 Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus Ann Surg 238 4 467 484 10.1097/01.sla.0000089851.41115.1b 14530719 discussion 484-465
267. J Ponce B Haynes S Paynter R Fromm B Lindsey A Shafer E Manahan C Sutterfield 2004 Effect of lap-band-induced weight loss on type 2 diabetes mellitus and hypertension Obes Surg 14 10 1335 1342 10.1381/0960892042583932 15603648 (Pubitemid 39658319)
268. P Zimmet R Turner D McCarty M Rowley I Mackay 1999 Crucial points at diagnosis. Type 2 diabetes or slow type 1 diabetes Diabetes Care 22 2 B59 64 10097901
269. M Deitel 2009 Slow-progression, autoimmune, type 1 diabetes in adults: a cause of failure of resolution of diabetes after bariatric surgery Surg Obes Relat Dis 5 6 705 706 10.1016/j.soard.2009.09.007 19879815
270. M Deitel 2009 From bariatric to metabolic surgery in non-obese subjects: time for some caution Arq Bras Endocrinol Metabol 53 2 246 251 19466217
271. M Deitel 2008 Surgery for diabetes at lower BMI: some caution Obes Surg 18 10 1211 1214 10.1007/s11695-008-9674-9 18758867